KR20220149519A - B형 및 d형 간염의 치료 및 예방을 위한 조성물 및 방법 - Google Patents

B형 및 d형 간염의 치료 및 예방을 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20220149519A
KR20220149519A KR1020227029043A KR20227029043A KR20220149519A KR 20220149519 A KR20220149519 A KR 20220149519A KR 1020227029043 A KR1020227029043 A KR 1020227029043A KR 20227029043 A KR20227029043 A KR 20227029043A KR 20220149519 A KR20220149519 A KR 20220149519A
Authority
KR
South Korea
Prior art keywords
gly
arg
glu
lys
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227029043A
Other languages
English (en)
Korean (ko)
Inventor
맛티 셀베리
라르스 프렐린
Original Assignee
스벤스카 박신파브리셴 프로둑숀 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스벤스카 박신파브리셴 프로둑숀 아베 filed Critical 스벤스카 박신파브리셴 프로둑숀 아베
Publication of KR20220149519A publication Critical patent/KR20220149519A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
    • C12N2760/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Beans For Foods Or Fodder (AREA)
KR1020227029043A 2020-01-28 2021-01-26 B형 및 d형 간염의 치료 및 예방을 위한 조성물 및 방법 Pending KR20220149519A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062966970P 2020-01-28 2020-01-28
US62/966,970 2020-01-28
PCT/US2021/015126 WO2021154752A1 (en) 2020-01-28 2021-01-26 Compositions and methods for treating and preventing hepatitis b and d

Publications (1)

Publication Number Publication Date
KR20220149519A true KR20220149519A (ko) 2022-11-08

Family

ID=74673345

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227029043A Pending KR20220149519A (ko) 2020-01-28 2021-01-26 B형 및 d형 간염의 치료 및 예방을 위한 조성물 및 방법

Country Status (9)

Country Link
US (1) US20230079898A1 (cg-RX-API-DMAC7.html)
EP (1) EP4096711A1 (cg-RX-API-DMAC7.html)
JP (1) JP7855515B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220149519A (cg-RX-API-DMAC7.html)
CN (1) CN115335075A (cg-RX-API-DMAC7.html)
AU (1) AU2021214939A1 (cg-RX-API-DMAC7.html)
CA (1) CA3169407A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022009169A (cg-RX-API-DMAC7.html)
WO (1) WO2021154752A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101564533B (zh) * 2009-06-12 2012-01-04 东南大学 戊型肝炎蛋白-核酸复合疫苗及其制备方法
CN102895659B (zh) * 2011-07-29 2014-10-29 复旦大学 一种防治老年痴呆症复合疫苗及其制备方法
US10905760B2 (en) 2016-01-28 2021-02-02 Svenska Vaccinfabriken Produktion Ab Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes
AU2017332854B2 (en) * 2016-09-21 2024-11-14 The Governors Of The University Of Alberta Hepatitis C virus immunogenic compositions and methods of use thereof

Also Published As

Publication number Publication date
JP7855515B2 (ja) 2026-05-08
AU2021214939A1 (en) 2022-09-15
CN115335075A (zh) 2022-11-11
JP2023512526A (ja) 2023-03-27
CA3169407A1 (en) 2021-08-05
EP4096711A1 (en) 2022-12-07
US20230079898A1 (en) 2023-03-16
WO2021154752A1 (en) 2021-08-05
MX2022009169A (es) 2022-12-08

Similar Documents

Publication Publication Date Title
AU2019202515B2 (en) Vaccine composition
KR102286397B1 (ko) 신규 백신 면역보조제
CN111533812B (zh) 针对sars-cov-2病毒的dna疫苗及其用途
KR20200101416A (ko) B형 간염 바이러스(hbv) 백신 및 그 용도
EP2391383B1 (en) Codon-optimized hepatitis b virus core antigen (hbcag)
KR20230015914A (ko) 캡핑 화합물, 조성물 및 이의 사용 방법
US20190083607A1 (en) Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes
JP2025179041A (ja) 帯状疱疹mRNAワクチン及びその調製方法と使用
KR20220042116A (ko) B형 간염 바이러스(HBV) 백신 및 HBV-타케팅 RNAi의 조합
CN115335390A (zh) 基于SARS-CoV-2的S蛋白的疫苗和组合物
CN115666634A (zh) 用于治疗和预防冠状病毒的组合物和方法
CZ20011521A3 (cs) Farmaceutický prostředek obsahující fragmenty DNA kódující antigenní protein vykazující protinádorový účinek
RU2812764C1 (ru) Композиции и способы для лечения и предотвращения гепатита в и d
CN114340663A (zh) 乙型肝炎病毒(HBV)疫苗和靶向HBV的RNAi的组合
CN115335075A (zh) 治疗和预防乙型肝炎和丁型肝炎的组合物和方法
HK40083708A (en) Compositions and methods for treating and preventing hepatitis b and d
JP2024516882A (ja) 構築物と免疫刺激性化合物の共発現
KR20240087649A (ko) B형 및 d형 간염의 치료 및 예방을 위한 조성물 및 방법
KR20220041079A (ko) B형 간염 바이러스(hbv) 백신 및 항-pd-1 항체의 조합
KR20210084125A (ko) 신규 사이토메갈로바이러스 dna 백신 컨스트럭트 및 그의 용도
HK40037585A (en) Novel vaccine adjuvant
JP2026022933A (ja) B型肝炎ウイルスワクチン
JPWO2005090576A1 (ja) 百日咳感染症予防用dna構築物
HK1165694B (en) Codon-optimized hepatitis b virus core antigen (hbcag)

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000